Watchlist 9/21/17

Note that all stocks in the watchlist are either trending towards a bullish technical chart or currently in one.  Please do your own Due Diligence before considering investing in these stocks.

ACHN:  136.61M float  Achillion Pharmaceuticals, Inc. (ACHN) announced today that members of the senior management team will provide a corporate update at the 2017 Leerink Partners Rare Disease Roundtable Series on Wednesday, September 27, 2017 at 10:00 a.m. ET at the Lotte New York Palace Hotel in New York City, NY.


CRR: 22.68M float. The technical chart put the close on Wednesday right at a double top.  With strong volume and an increasing RSI and MACD, the price should continue to go up IMO.


CATB: 20.63M Float.  Great momentum for the past month.  Easily surpassed previously resistance levels.  Now it should test the 2.05 resistance.  We should continue to to see momentum for at least another week due to the announcement that the company will present results on October 4th

On September 14th, Catabasis Pharmaceuticals, Inc. (CATB), a clinical-stage biopharmaceutical company, today announced that the Company will present results from the open-label extension of the MoveDMD trial following 24 and 36 weeks of edasalonexent treatment in boys with Duchenne Muscular Dystrophy (DMD) at the 22nd International Congress of the World Muscle Society. The late breaking abstract and results will be available in the late breaking poster session starting at 10:30am CEST on Wednesday, October 4, 2017. The International Congress of the World Muscle Society is being held October 3 – 7, 2017, at the Palais du Grand Large in Saint Malo, France.


CHGG: 102.17M float.  CHGG continues to follow its upward channel since May.  The technical indicators have started to turn upwards for the first time in two months.  This could easily spur the price on to the next level of 17.50 to 18.00.  

It looks like the news on August 29th was well received by Investors. 

"CHGG, the leading student-first connected learning platform, has teamed up with Kaplan Test Prep for developing distinct test prep services exclusively through Chegg at minimum pocket pinch.  The latest partnership will make Kaplan the exclusive test prep partner for Chegg. Founded in 1938, Kaplan Test Prep is the world leader in providing educational and career services to individuals, schools and businesses.  Hence, the pact will help test-takers to get Kaplan’s industry-leading comprehensive prep courses, practice products, and books for the GRE, GMAT, LSAT, MCAT, SAT, and ACT through alongside Chegg Tutors, Chegg’s 24/7 online expert tutor matching service."


FTFT: Very low float of 2.8M.  The stock had a big run-up on Wednesday shooting past the Pivot Point resistance level.  The last 30 minutes of trading on Wednesday also saw strong momentum building.  Based on this, I believe there may be another big upward price movement on Thursday.

Note the chart below is a 15-minute 5-day chart.  

Member Login
Welcome, (First Name)!

Forgot? Show
Log In
Enter Member Area
My Profile Not a member? Sign up. Log Out